Breast diseases

PubMed Free Full Text

Breast cancer treatment: tyrosine kinase inhibitors

Brazil

• Breast Cancer : Targets and Therapy
  • Lapatinib in patients with metastatic breast cancer following initial treatment with trastuzumab: an economic analysis from the Brazilian public health care perspective [2012]

China

• Experimental and Therapeutic Medicine
  • Tyrosine kinase inhibitors in breast cancer (Review) [2022]

• OncoTargets and Therapy
  • Lapatinib for the treatment of breast cancer in the People’s Republic of China [2014]

• PLoS ONE
  • Pyrotinib versus lapatinib therapy for HER2 positive metastatic breast cancer patients after first-line treatment failure: A meta-analysis and systematic review [2023]

International

• ESMO Open
  • Efficacy of tyrosine kinase inhibitors for the treatment of patients with HER2-positive breast cancer with brain metastases: a systematic review and meta-analysis [2022]

Italy, Spain

• Breast
  • "Positioning of tucatinib in the new clinical scenario of HER2-positive metastatic breast cancer: An Italian and Spanish consensus paper" [2024]

United Kingdom

• National Institute for Health and Care Excellence
  • Neratinib for extended adjuvant treatment of hormone receptor-positive, HER2-positive early stage breast cancer after adjuvant trastuzumab [2019]

{Related topics}

• Topic
  • Breast cancer treatment